Strive Asset Management has raised $750 million to pursue the strategy while Ramaswamy runs to be Ohio’s governor.

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

In partnership with the Silicon Valley Business Journal, we'll honor the Bay Area's top companies recognized as the Best ...

Celebrating the top Seed stage investors in 2025 who made early bets on the startups driving today’s AI revolution.

Eli Lilly acquires SiteOne Therapeutics for up to $1B, signaling potential uptick in Big Pharma deals and focus on non-opioid ...

Indian CDMOs are strategically expanding through acquisitions in the US and Europe, driven by global pharma's nearshoring ...

Big Biotech Biogen is venturing into the city, paying $16 million in cash to partner up with an RNAi company to build ...

Health Secretary Robert F. Kennedy Jr. took aim at reputed journals such as the Lancet and said the agency will create ...

How unfortunate if taxes restrain the global cooperation so essential to progress, including life-saving cures.

Let's consider two corporations that could help you do better than average in the next decade: Eli Lilly (NYSE: LLY) and ...

The tariff war the U.S. is waging against most of the world stabilized somewhat earlier this month. But let's face facts -- ...